Literature DB >> 16163254

Acute graft-versus-host disease.

Javier Bolaños-Meade1, Georgia B Vogelsang.   

Abstract

Acute graft-versus-host disease (aGVHD) continues to be a problem in allogeneic transplantation. Recent advances in the understanding of the induction and propagation of GVHD have lead to new transplant strategies and treatment of aGVHD. This overview covers the basic pathophysiology, prophylaxis and treatment of this disorder.

Entities:  

Mesh：

Year:  2004        PMID： 16163254

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


  6 in total

1.  Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD.

Authors:  Masayuki Nagasawa; Noriko Mitsuiki; Masakatsu Yanagimachi; Masahide Yamamoto; Tetsuya Fukuda; Osamu Miura; Ryutaro Oba; Akira Igarashi; Kinya Nagata; Tomohiro Morio
Journal:  Int J Hematol       Date:  2021-03-08       Impact factor: 2.490

2.  Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203).

Authors:  Javier Bolaños-Meade; Ran Reshef; Raphael Fraser; Mingwei Fei; Sunil Abhyankar; Zaid Al-Kadhimi; Amin M Alousi; Joseph H Antin; Sally Arai; Kate Bickett; Yi-Bin Chen; Lloyd E Damon; Yvonne A Efebera; Nancy L Geller; Sergio A Giralt; Parameswaran Hari; Shernan G Holtan; Mary M Horowitz; David A Jacobsohn; Richard J Jones; Jane L Liesveld; Brent R Logan; Margaret L MacMillan; Marco Mielcarek; Pierre Noel; Joseph Pidala; David L Porter; Iskra Pusic; Ronald Sobecks; Scott R Solomon; Daniel J Weisdorf; Juan Wu; Marcelo C Pasquini; John Koreth
Journal:  Lancet Haematol       Date:  2019-03       Impact factor: 18.959

3.  Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302.

Authors:  Javier Bolaños-Meade; Juan Wu; Brent R Logan; John E Levine; Vincent T Ho; Amin M Alousi; Daniel J Weisdorf; Leo Luznik
Journal:  Biol Blood Marrow Transplant       Date:  2012-12-12       Impact factor: 5.742

4.  Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.

Authors:  Javier Bolaños-Meade; Elizabeth Garrett-Mayer; Leo Luznik; Viki Anders; Jennifer Webb; Ephraim J Fuchs; Carol Ann Huff; William Matsui; Ivan M Borrello; Robert Brodsky; Yvette L Kasamon; Lode J Swinnen; Ian W Flinn; Richard F Ambinder; Richard J Jones; Allan D Hess; Georgia B Vogelsang
Journal:  Biol Blood Marrow Transplant       Date:  2007-08-03       Impact factor: 5.742

5.  Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen.

Authors:  J Bolaños-Meade; L Luznik; M Muth; W H Matsui; C A Huff; B D Smith; M Y Levy; Y L Kasamon; L J Swinnen; J D Powell; R A Brodsky; R F Ambinder; R J Jones; E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2008-11-03       Impact factor: 5.483

Review 6.  Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies.

Authors:  Nancy Y Villa; Masmudur M Rahman; Grant McFadden; Christopher R Cogle
Journal:  Viruses       Date:  2016-03-22       Impact factor: 5.048
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.